{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:54:24Z","timestamp":1793692464372,"version":"4.5.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100032090","name":"Universit\u00e4t der Bundeswehr M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100032090","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Intercellular communication in the tumor microenvironment has a major impact on therapeutic outcomes. In particular, highly aggressive cancers such as glioblastoma benefit from efficient cellular communication by developing resistance to therapy or by infiltrating surrounding tissue to escape radiotherapy. Tiny membrane tunnels, such as tunneling nanotubes (TNTs), can serve as an effective communication tool for tumor cells. With these structures, the cells can build a large network that allows them to react and adapt to their environment as quickly as possible, thereby combating the therapy. In this study, we investigated the effects of chemotherapeutic agents on TNT networks in U87 MG cells to determine if they affect the number of TNTs and, consequently, possible therapeutic outcomes. The effect of drugs on TNT stability may be related to their effects on actin and tubulin, which are known stabilizers of membrane structures. Therefore, we also analyzed the cytoskeletal content of TNTs in U87 MG cells and examined the effect of the actin polymerization inhibitor cytochalasin B (CytoB) on TNT formation and networks. CytoB reduced the number of TNTs in this study, suggesting that actin, as a cytoskeletal component, is required for developing TNT networks. In contrast, the chemotherapeutic agents temozolomide (TMZ) and cytarabine (AraC) do not affect TNTs and actin content. As TNT networks are closely linked to increased therapy resistance of certain tumors, we believe that the lack of suppression of TNTs is a major problem in current glioblastoma therapy and should be a target for further research in the future.<\/jats:p>","DOI":"10.1186\/s12885-025-15204-7","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:27:16Z","timestamp":1762266436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of chemotherapeutic drugs and cytochalasin B on tunneling nanotubes in U87 MG cells"],"prefix":"10.1186","volume":"25","author":[{"given":"Nicole","family":"Matejka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"5660","key":"15204_CR1","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1126\/science.1093133","volume":"303","author":"A Rustom","year":"2004","unstructured":"Rustom A, Saffrich R, Markovic I, Walther P, Gerdes H-H. Nanotubular highways for intercellular organelle transport. Science. 2004;303(5660):1007\u201310.","journal-title":"Science"},{"issue":"1","key":"15204_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13014-019-1416-8","volume":"14","author":"N Matejka","year":"2019","unstructured":"Matejka N, Reindl J. Perspectives of cellular communication through tunneling nanotubes in cancer cells and the connection to radiation effects. Radiat Oncol. 2019;14(1):218. https:\/\/doi.org\/10.1186\/s13014-019-1416-8.","journal-title":"Radiat Oncol"},{"issue":"1","key":"15204_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/cancers6010226","volume":"6","author":"M-D-M Inda","year":"2014","unstructured":"Inda M-D-M, Bonavia R, Seoane J. Glioblastoma multiforme: a look inside its heterogeneous nature. Cancers. 2014;6(1):226\u201339.","journal-title":"Cancers"},{"issue":"6380","key":"15204_CR4","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.aar5555","volume":"359","author":"F Winkler","year":"2018","unstructured":"Winkler F, Wick W. Harmful networks in the brain and beyond. Science. 2018;359(6380):1100\u20131.","journal-title":"Science"},{"issue":"7580","key":"15204_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nature16071","volume":"528","author":"M Osswald","year":"2015","unstructured":"Osswald M, Jung E, Sahm F, Solecki G, Venkataramani V, Blaes J, et al. Brain tumour cells interconnect to a functional and resistant network. Nature. 2015;528(7580):93\u20138.","journal-title":"Nature"},{"key":"15204_CR6","doi-asserted-by":"crossref","unstructured":"Osswald M, Jung E, Wick W, Winkler F. Tunneling nanotube-like structures in brain tumors. Cancer Rep 2019;2(6):e1181.","DOI":"10.1002\/cnr2.1181"},{"key":"15204_CR7","doi-asserted-by":"publisher","unstructured":"Matejka N, Reindl J. Influence of \u03b1-Particle Radiation on Intercellular Communication Networks of Tunneling Nanotubes in U87 Glioblastoma Cells. Front. Oncol. 2020; 10:1691. Available from: URL: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fonc.2020.01691\/full","DOI":"10.3389\/fonc.2020.01691\/full"},{"issue":"6","key":"15204_CR8","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1073\/pnas.0401851102","volume":"102","author":"A Levchenko","year":"2005","unstructured":"Levchenko A, Mehta BM, Niu X, Kang G, Villafania L, Way D, et al. Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. Proc Natl Acad Sci U S A. 2005;102(6):1933\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"15204_CR9","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1074\/jbc.M111.312157","volume":"287","author":"J Pasquier","year":"2012","unstructured":"Pasquier J, Galas L, Boulang\u00e9-Lecomte C, Rioult D, Bultelle F, Magal P, et al. Different modalities of intercellular membrane exchanges mediate cell-to-cell p-glycoprotein transfers in MCF-7 breast cancer cells. J Biol Chem. 2012;287(10):7374\u201387.","journal-title":"J Biol Chem"},{"issue":"5","key":"15204_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.trsl.2014.05.011","volume":"164","author":"V Thayanithy","year":"2014","unstructured":"Thayanithy V, Dickson EL, Steer C, Subramanian S, Lou E. Tumor-stromal cross talk: direct cell-to-cell transfer of oncogenic microRNAs via tunneling nanotubes. Transl Res. 2014;164(5):359\u201365.","journal-title":"Transl Res"},{"issue":"14","key":"15204_CR11","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1002\/smll.201503606","volume":"12","author":"M Rehberg","year":"2016","unstructured":"Rehberg M, Nekolla K, Sellner S, Praetner M, Mildner K, Zeuschner D, et al. Intercellular transport of nanomaterials is mediated by membrane nanotubes in vivo. Small. 2016;12(14):1882\u201390.","journal-title":"Small"},{"issue":"6","key":"15204_CR12","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1021\/nn1002198","volume":"4","author":"K He","year":"2010","unstructured":"He K, Luo W, Zhang Y, Liu F, Liu D, Xu L, et al. Intercellular transportation of quantum dots mediated by membrane nanotubes. ACS Nano. 2010;4(6):3015\u201322.","journal-title":"ACS Nano"},{"key":"15204_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12100966","author":"W L\u00f6scher","year":"2020","unstructured":"L\u00f6scher W, Gericke B. Novel intrinsic mechanisms of active drug extrusion at the blood-brain barrier: potential targets for enhancing drug delivery to the brain? Pharmaceutics. 2020. https:\/\/doi.org\/10.3390\/pharmaceutics12100966.","journal-title":"Pharmaceutics"},{"key":"15204_CR14","doi-asserted-by":"crossref","unstructured":"Ottonelli I, Caraffi R, Tosi G, Vandelli MA, Duskey JT, Ruozi B. Tunneling nanotubes: A new target for nanomedicine? Int J Mol Sci. 2022;23(4):2237.","DOI":"10.3390\/ijms23042237"},{"issue":"Pt 10","key":"15204_CR15","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/brain\/awm204","volume":"130","author":"D Krex","year":"2007","unstructured":"Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, et al. Long-term survival with glioblastoma multiforme. Brain. 2007;130(Pt 10):2596\u2013606.","journal-title":"Brain"},{"key":"15204_CR16","doi-asserted-by":"crossref","unstructured":"Babu R, Komisarow JM, Agarwal VJ, Rahimpour S, Iyer A, Britt D et al. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival. Journal of Neurosurgery. 2016; 124(4):998\u20131007. Available from: URL: https:\/\/thejns.org\/view\/journals\/j-neurosurg\/124\/4\/article-p998.xml","DOI":"10.3171\/2015.4.JNS142200"},{"issue":"5897","key":"15204_CR17","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X, Lin JC-H, Leary RJ, Angenendt P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321(5897):1807\u201312.","journal-title":"Science"},{"issue":"7","key":"15204_CR18","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.ajpath.2015.02.023","volume":"185","author":"I Crespo","year":"2015","unstructured":"Crespo I, Vital AL, Gonzalez-Tablas M, Patino MC, Otero A, Lopes MC, et al. Molecular and genomic alterations in glioblastoma multiforme. Am J Pathol. 2015;185(7):1820\u201333.","journal-title":"Am J Pathol"},{"key":"15204_CR19","doi-asserted-by":"crossref","unstructured":"Wank M, Schilling D, Schmid TE, Meyer B, Gempt J, Barz M et al. Human glioma migration and infiltration properties as a target for personalized radiation medicine. Cancers. 2018;10(11):456.","DOI":"10.3390\/cancers10110456"},{"key":"15204_CR20","doi-asserted-by":"crossref","unstructured":"Ou A, Yung WKA, Majd N. Molecular mechanisms of treatment resistance in glioblastoma. Int J Mol Sci. 2020;22(1):351 .","DOI":"10.3390\/ijms22010351"},{"key":"15204_CR21","doi-asserted-by":"publisher","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","volume":"171","author":"W Wu","year":"2021","unstructured":"Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, et al. Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance. Pharmacol Res. 2021;171:105780.","journal-title":"Pharmacol Res"},{"key":"15204_CR22","doi-asserted-by":"crossref","unstructured":"Soni V, Adhikari M, Simonyan H, Lin L, Sherman JH, Young CN et al. In Vitro and In Vivo Enhancement of Temozolomide Effect in Human Glioblastoma by Non-Invasive Application of Cold Atmospheric Plasma. Cancers. 2021;13(17):4485 .","DOI":"10.3390\/cancers13174485"},{"issue":"7942","key":"15204_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41586-022-05520-4","volume":"613","author":"D Hausmann","year":"2023","unstructured":"Hausmann D, Hoffmann DC, Venkataramani V, Jung E, Horschitz S, Tetzlaff SK, et al. Autonomous rhythmic activity in glioma networks drives brain tumour growth. Nature. 2023;613(7942):179\u201386.","journal-title":"Nature"},{"issue":"4","key":"15204_CR24","first-page":"299","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the Art and future directions. CA Cancer J Clin. 2020;70(4):299\u2013312.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"15204_CR25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396.","journal-title":"N Engl J Med"},{"issue":"3","key":"15204_CR26","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11060-018-2923-4","volume":"139","author":"M Wank","year":"2018","unstructured":"Wank M, Schilling D, Reindl J, Meyer B, Gempt J, Motov S, et al. Evaluation of radiation-related invasion in primary patient-derived glioma cells and validation with established cell lines: impact of different radiation qualities with differing LET. J Neurooncol. 2018;139(3):583\u201390.","journal-title":"J Neurooncol"},{"key":"15204_CR27","doi-asserted-by":"crossref","unstructured":"Han X, Wang X. Opportunities and challenges in tunneling nanotubes research: how Far from clinical application? Int J Mol Sci. 2021;22(5):2306.","DOI":"10.3390\/ijms22052306"},{"issue":"2","key":"15204_CR28","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/jcp.27072","volume":"234","author":"R Mittal","year":"2019","unstructured":"Mittal R, Karhu E, Wang J-S, Delgado S, Zukerman R, Mittal J, et al. Cell communication by tunneling nanotubes: implications in disease and therapeutic applications. J Cell Physiol. 2019;234(2):1130\u201346.","journal-title":"J Cell Physiol"},{"key":"15204_CR29","doi-asserted-by":"crossref","unstructured":"Pinto G, Brou C, Zurzolo C. Tunneling Nanotubes: The Fuel of Tumor Progression? Trends in Cancer. 2020; 6(10):874\u201388. Available from: URL: https:\/\/www.cell.com\/trends\/cancer\/fulltext\/s2405-8033(20)30155-2","DOI":"10.1016\/j.trecan.2020.04.012"},{"issue":"6","key":"15204_CR30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.2174\/1568009618666171129222637","volume":"18","author":"P Sahu","year":"2018","unstructured":"Sahu P, Jena SR, Samanta L. Tunneling nanotubes: A versatile target for cancer therapy. Curr Cancer Drug Targets. 2018;18(6):514\u201321.","journal-title":"Curr Cancer Drug Targets"},{"issue":"6","key":"15204_CR31","first-page":"e1185","volume":"2","author":"VS Venkatesh","year":"2019","unstructured":"Venkatesh VS, Lou E. Tunneling nanotubes: A Bridge for heterogeneity in glioblastoma and a new therapeutic target? Cancer Rep. 2019;2(6):e1185.","journal-title":"Cancer Rep"},{"issue":"4","key":"15204_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4161\/cib.20569","volume":"5","author":"E Lou","year":"2012","unstructured":"Lou E, Fujisawa S, Barlas A, Romin Y, Manova-Todorova K, Moore MAS, et al. Tunneling nanotubes: A new paradigm for studying intercellular communication and therapeutics in cancer. Commun Integr Biol. 2012;5(4):399\u2013403.","journal-title":"Commun Integr Biol"},{"key":"15204_CR33","doi-asserted-by":"crossref","unstructured":"Khattar KE, Safi J, Rodriguez A-M, Vignais M-L. Intercellular communication in the brain through tunneling nanotubes. Cancers. 2022;14(5):1207.","DOI":"10.3390\/cancers14051207"},{"key":"15204_CR34","doi-asserted-by":"crossref","unstructured":"Taiarol L, Formicola B, Fagioli S, Sierri G, D\u2019Aloia A, Kravicz M et al. The 3.0 Cell Communication: New Insights in the Usefulness of Tunneling Nanotubes for Glioblastoma Treatment. Cancers. 2021; 13(16):4001. Available from: URL: https:\/\/www.mdpi.com\/2072-6694\/13\/16\/4001","DOI":"10.3390\/cancers13164001"},{"issue":"1","key":"15204_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29391-w","volume":"8","author":"M Omsland","year":"2018","unstructured":"Omsland M, Pise-Masison C, Fujikawa D, Galli V, Fenizia C, Parks RW, et al. Inhibition of tunneling nanotube (TNT) formation and human T-cell leukemia virus type 1 (HTLV-1) transmission by cytarabine. Sci Rep. 2018;8(1):11118.","journal-title":"Sci Rep"},{"issue":"5","key":"15204_CR36","doi-asserted-by":"publisher","first-page":"7946","DOI":"10.18632\/oncotarget.13853","volume":"8","author":"M Omsland","year":"2017","unstructured":"Omsland M, Bruserud \u00d8, Gjertsen BT, Andresen V. Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-\u03baB inhibition in acute myeloid leukemia (AML). Oncotarget. 2017;8(5):7946\u201363.","journal-title":"Oncotarget"},{"issue":"10","key":"15204_CR37","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1002\/cncr.23884","volume":"113","author":"U Linz","year":"2008","unstructured":"Linz U. Chemotherapy for glioblastoma: is costly better? Cancer. 2008;113(10):2617\u201322.","journal-title":"Cancer"},{"key":"15204_CR38","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.2147\/DDDT.S135711","volume":"11","author":"K-H Zhao","year":"2017","unstructured":"Zhao K-H, Zhang C, Bai Y, Li Y, Kang X, Chen J-X, et al. Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K\/Akt\/mTOR pathway. Drug Des Devel Ther. 2017;11:1905\u201315.","journal-title":"Drug Des Devel Ther"},{"key":"15204_CR39","doi-asserted-by":"publisher","unstructured":"Frankel BM, Cachia D, Patel SJ, Das A. Targeting Subventricular Zone Progenitor Cells with Intraventricular Liposomal Encapsulated Cytarabine in Patients with Secondary Glioblastoma: A Report of Two Cases. SN Compr. Clin. Med. 2020; 2(6):836\u201343. Available from: URL: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s42399-020-00322-z","DOI":"10.1007\/s42399-020-00322-z"},{"issue":"7","key":"15204_CR40","first-page":"2585","volume":"6","author":"HS Friedman","year":"2000","unstructured":"Friedman HS, Kerby T, Calvert H. Temozolomide and treatment of malignant Glioma1. Clin Cancer Res. 2000;6(7):2585\u201397.","journal-title":"Clin Cancer Res"},{"key":"15204_CR41","unstructured":"Faruqi A, Tadi P, StatPearls. Cytarabine. Treasure Island (FL); 2023."},{"issue":"2","key":"15204_CR42","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0092-8674(80)90619-4","volume":"20","author":"S MacLean-Fletcher","year":"1980","unstructured":"MacLean-Fletcher S, Pollard TD. Mechanism of action of cytochalasin B on actin. Cell. 1980;20(2):329\u201341.","journal-title":"Cell"},{"issue":"9","key":"15204_CR43","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.febslet.2009.03.065","volume":"583","author":"NV Bukoreshtliev","year":"2009","unstructured":"Bukoreshtliev NV, Wang X, Hodneland E, Gurke S, Barroso JFV, Gerdes H-H. Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells. FEBS Lett. 2009;583(9):1481\u20138.","journal-title":"FEBS Lett"},{"issue":"8","key":"15204_CR44","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/stem.2372","volume":"34","author":"MV Jackson","year":"2016","unstructured":"Jackson MV, Morrison TJ, Doherty DF, McAuley DF, Matthay MA, Kissenpfennig A, et al. Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS. Stem Cells. 2016;34(8):2210\u201323.","journal-title":"Stem Cells"},{"key":"15204_CR45","doi-asserted-by":"crossref","unstructured":"Wang X, Gerdes H-H. Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells. Cell Death Differ. 2015; 22(7):1181\u201391. Available from: URL: https:\/\/www.nature.com\/articles\/cdd2014211","DOI":"10.1038\/cdd.2014.211"},{"key":"15204_CR46","doi-asserted-by":"crossref","unstructured":"Matejka N, Amarlou A, Neubauer J, Rudigkeit S, Reindl J. High-Resolution Microscopic Characterization of Tunneling Nanotubes in Living U87 MG and LN229 Glioblastoma Cells. Cells. 2024; 13(5):464. Available from: URL: https:\/\/www.mdpi.com\/2073-4409\/13\/5\/464","DOI":"10.3390\/cells13050464"},{"issue":"6","key":"15204_CR47","doi-asserted-by":"publisher","DOI":"10.1088\/1478-3975\/12\/6\/066005","volume":"12","author":"J Reindl","year":"2015","unstructured":"Reindl J, Drexler GA, Girst S, Greubel C, Siebenwirth C, Drexler SE, et al. Nanoscopic exclusion between Rad51 and 53BP1 after ion irradiation in human HeLa cells. Phys Biol. 2015;12(6):66005.","journal-title":"Phys Biol"},{"issue":"7","key":"15204_CR48","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3109\/0284186X.2013.818255","volume":"52","author":"SE Combs","year":"2013","unstructured":"Combs SE, Kessel K, Habermehl D, Haberer T, J\u00e4kel O, Debus J. Proton and carbon ion radiotherapy for primary brain tumors and tumors of the skull base. Acta Oncol. 2013;52(7):1504\u20139.","journal-title":"Acta Oncol"},{"issue":"9","key":"15204_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101450","volume":"23","author":"S Valdebenito","year":"2020","unstructured":"Valdebenito S, Audia A, Bhat KPL, Okafo G, Eugenin EA. Tunneling nanotubes mediate adaptation of glioblastoma cells to Temozolomide and ionizing radiation treatment. iScience. 2020;23(9):101450.","journal-title":"iScience"},{"issue":"2","key":"15204_CR50","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/09553000802641151","volume":"85","author":"SE Combs","year":"2009","unstructured":"Combs SE, Bohl J, Elsasser T, Weber K-J, Schulz-Ertner D, Debus J, et al. Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and Temozolomide in glioblastoma cell lines. Int J Radiat Biol. 2009;85(2):126\u201337.","journal-title":"Int J Radiat Biol"},{"issue":"3","key":"15204_CR51","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.ijrobp.2007.03.002","volume":"68","author":"SE Combs","year":"2007","unstructured":"Combs SE, Schulz-Ertner D, Roth W, Herold-Mende C, Debus J, Weber K-J. In vitro responsiveness of glioma cell lines to multimodality treatment with radiotherapy, temozolomide, and epidermal growth factor receptor inhibition with cetuximab. Int J Radiat Oncol Biol Phys. 2007;68(3):873\u201382.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"19","key":"15204_CR52","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1088\/0031-9155\/57\/19\/5889","volume":"57","author":"TE Schmid","year":"2012","unstructured":"Schmid TE, Greubel C, Hable V, Zlobinskaya O, Michalski D, Girst S, et al. Low LET protons focused to submicrometer shows enhanced radiobiological effectiveness. Phys Med Biol. 2012;57(19):5889\u2013907.","journal-title":"Phys Med Biol"},{"issue":"11","key":"15204_CR53","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/boc.201500004","volume":"107","author":"M B\u00e9nard","year":"2015","unstructured":"B\u00e9nard M, Schapman D, Lebon A, Monterroso B, Bellenger M, Le Foll F, et al. Structural and functional analysis of tunneling nanotubes (TnTs) using gCW STED and gconfocal approaches. Biol Cell. 2015;107(11):419\u201325.","journal-title":"Biol Cell"},{"issue":"Pt 5","key":"15204_CR54","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1242\/jcs.083279","volume":"125","author":"S Abounit","year":"2012","unstructured":"Abounit S, Zurzolo C. Wiring through tunneling nanotubes\u2013from electrical signals to organelle transfer. J Cell Sci. 2012;125(Pt 5):1089\u201398.","journal-title":"J Cell Sci"},{"issue":"1","key":"15204_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08178-7","volume":"10","author":"A Sartori-Rupp","year":"2019","unstructured":"Sartori-Rupp A, Cordero Cervantes D, Pepe A, Gousset K, Delage E, Corroyer-Dulmont S, et al. Correlative cryo-electron microscopy reveals the structure of TNTs in neuronal cells. Nat Commun. 2019;10(1):342.","journal-title":"Nat Commun"},{"key":"15204_CR56","doi-asserted-by":"crossref","unstructured":"Drab M, Stopar D, Kralj-Igli\u010d V, Igli\u010d A. Inception Mech Tunneling Nanotubes Cells. 2019;8(6):626.","DOI":"10.3390\/cells8060626"},{"issue":"12","key":"15204_CR57","doi-asserted-by":"publisher","first-page":"8476","DOI":"10.4049\/jimmunol.177.12.8476","volume":"177","author":"B Onfelt","year":"2006","unstructured":"Onfelt B, Nedvetzki S, Benninger RKP, Purbhoo MA, Sowinski S, Hume AN, et al. Structurally distinct membrane nanotubes between human macrophages support long-distance vesicular traffic or surfing of bacteria. J Immunol. 2006;177(12):8476\u201383.","journal-title":"J Immunol"},{"issue":"1","key":"15204_CR58","doi-asserted-by":"publisher","DOI":"10.4161\/cib.27934","volume":"7","author":"MW Austefjord","year":"2014","unstructured":"Austefjord MW, Gerdes H-H, Wang X. Tunneling nanotubes: diversity in morphology and structure. Commun Integr Biol. 2014;7(1):e27934.","journal-title":"Commun Integr Biol"},{"issue":"1\u20132","key":"15204_CR59","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0027-5107(00)00065-8","volume":"455","author":"M Fenech","year":"2000","unstructured":"Fenech M. The in vitro micronucleus technique. Mutat Res. 2000;455(1\u20132):81\u201395.","journal-title":"Mutat Res"},{"key":"15204_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","volume":"19","author":"O van Tellingen","year":"2015","unstructured":"van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. Drug Resist Updat. 2015;19:1\u201312.","journal-title":"Drug Resist Updat"},{"issue":"11","key":"15204_CR61","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMoa1010222","volume":"364","author":"B L\u00f6wenberg","year":"2011","unstructured":"L\u00f6wenberg B, Pabst T, Vellenga E, van Putten W, Schouten HC, Graux C, et al. Cytarabine dose for acute myeloid leukemia. N Engl J Med. 2011;364(11):1027\u201336.","journal-title":"N Engl J Med"},{"issue":"2","key":"15204_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian H, Kadia T, DiNardo C, Daver N, Borthakur G, Jabbour E, et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 2021;11(2):41.","journal-title":"Blood Cancer J"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15204-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15204-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15204-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:04:14Z","timestamp":1762311854000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15204-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15204"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15204-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1709"}}